Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from MedAdvisor Limited ( (AU:MDR) ).
MedAdvisor Limited has announced the application for quotation of 432,902 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of the company’s strategy to leverage financial instruments to support its operations and growth within the digital health sector, potentially impacting its market position and offering opportunities for stakeholders.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, focusing on digital health solutions. The company provides platforms and services that enhance medication management and patient engagement, primarily targeting pharmacies and healthcare providers.
Average Trading Volume: 819,524
Technical Sentiment Signal: Sell
Current Market Cap: A$15.18M
See more insights into MDR stock on TipRanks’ Stock Analysis page.